Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000161

Director sold 22,321 shares at an average $75.55 ($1,686,302)

  • Director acquired 22,321 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KLEIN JOSEPH III · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-01 Exercise or conversion : show line 1 in the form 10b5-1 +12,000 $38.06 $456,720 23,014 D
2026-04-01 Exercise or conversion : show line 2 in the form 10b5-1 +10,321 $41.08 $423,987 33,335 D
2026-04-01 Sale : show line 3 in the form 10b5-1 −20,105 $75.50 $1,517,988 13,230 D
2026-04-01 Sale : show line 4 in the form 10b5-1 −2,216 $75.95 $168,314 11,014 D
Open-market sales · 22,321 sh · avg $75.55 · $1,686,302

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-01 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −12,000 0 D
2026-04-01 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −10,321 0 D
Loading xslF345X06/edgardoc.xml…